Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
133
datasets available to search
ShareScore release 0.9.0
Dataset results
133 results for “age-related macular degeneration (AMD)”
Tools to Optimize Patient Presentation After Onset of Exudative Age-Related Macular Degeneration (AMD)
ClinicalTrials.gov study NCT01337414. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Evaluation of the Performance of Self-monitoring Optimized by Therapeutic Education in the Recurrence of Wet Age-related Macular Degeneration (AMD)
ClinicalTrials.gov study NCT04032808. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Subretinal Lucentis for Hemorrhagic Age-related Macular Degeneration (AMD)
ClinicalTrials.gov study NCT00538538. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Real-world Evaluation of BEOVU (Brolucizumab) Effectiveness and Durability for Treatment of Neovascular (Wet) Age-related Macular Degeneration (AMD)
ClinicalTrials.gov study NCT06184360. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study to Test How Well Different Doses of BI 771716 Are Tolerated by People With an Advanced Form of Age-related Macular Degeneration (AMD) Called Geographic Atrophy
ClinicalTrials.gov study NCT06006585. IPD Sharing: NO. Countries: 1. Publications: 0.
A Multicenter, Proof-Of-Concept Study Of Intravitreal AL-78898A In Patients With Geographic Atrophy (GA) Associated With Age-Related Macular Degeneration (AMD)
ClinicalTrials.gov study NCT01603043. IPD Sharing: Not stated. Countries: 0. Publications: 0.
A Study to Test Whether BI 771716 Helps People With an Advanced Form of Age-related Macular Degeneration (AMD) Called Geographic Atrophy
ClinicalTrials.gov study NCT06722157. IPD Sharing: YES. Countries: 1. Publications: 0.
Impact of Home Monitoring to Decrease the Treatment Burden for Neovascular Age-related Macular Degeneration (AMD)
ClinicalTrials.gov study NCT01863199. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Genetics Study of Wet Age-Related Macular Degeneration (AMD) Non-Responders to Vascular Endothelial Growth Factor (VEGF) Therapy
ClinicalTrials.gov study NCT01310686. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study to Evaluate Intravitreal JNJ-81201887 (AAVCAGsCD59) Compared to Sham Procedure for the Treatment of Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)
ClinicalTrials.gov study NCT05811351. IPD Sharing: YES. Countries: 17. Publications: 0.
Prevention of Vision Loss in Patients With Age-Related Macular Degeneration (AMD) by Intravitreal Injection of Bevacizumab and Ranibizumab
ClinicalTrials.gov study NCT00559715. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Age-Related Macular Degeneration (AMD) - Beta Study Telemedicine Assessment
ClinicalTrials.gov study NCT01083147. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Clinical Effectiveness Study Examining the Efficacy and Safety of ONS-5010 in Subjects With Neovascular Age-related Macular Degeneration (AMD)
ClinicalTrials.gov study NCT03834753. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Real-world Evaluation of Brolucizumab for the Treatment of Neovascular (Wet) Age-related Macular Degeneration (AMD) (IRIS Study)
ClinicalTrials.gov study NCT05082415. IPD Sharing: NO. Countries: 1. Publications: 0.
GTSCOPE - To Evaluate the Natural Progression of Dry Age-related Macular Degeneration (AMD)
ClinicalTrials.gov study NCT03894020. IPD Sharing: Not stated. Countries: 8. Publications: 0.
Development of Core Outcomes for Age-related Macular Degeneration (AMD) Interventions- Caregivers' Perspective
ClinicalTrials.gov study NCT02567604. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ESBA1008 Safety, Tolerability and Effects in Wet Age-Related Macular Degeneration (AMD) Patients
ClinicalTrials.gov study NCT01304693. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Real-world Evaluation of Prevalence of Ocular Adverse Events in Patients With Neovascular (Wet) Age-related Macular Degeneration (AMD) Who Received Anti-vascular Endothelial Growth Factor (VEGF) Agent
ClinicalTrials.gov study NCT05146687. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Safety of Intravitreal POT-4 Therapy for Patients With Neovascular Age-Related Macular Degeneration (AMD)
ClinicalTrials.gov study NCT00473928. IPD Sharing: Not stated. Countries: 1. Publications: 0.
IRay to Treat Polypoidal Choroidal Vasculopathy (PCV) Secondary to Age-Related Macular Degeneration (AMD
ClinicalTrials.gov study NCT01516294. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.